Capstone Financial Advisors Inc. Sells 1,724 Shares of CME Group Inc. $CME

Capstone Financial Advisors Inc. lowered its stake in shares of CME Group Inc. (NASDAQ:CME) by 8.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,100 shares of the financial services provider’s stock after selling 1,724 shares during the quarter. Capstone Financial Advisors Inc.’s holdings in CME Group were worth $4,989,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Jessup Wealth Management Inc grew its stake in shares of CME Group by 0.5% in the 2nd quarter. Jessup Wealth Management Inc now owns 7,969 shares of the financial services provider’s stock worth $2,197,000 after acquiring an additional 36 shares in the last quarter. First Horizon Advisors Inc. grew its position in CME Group by 0.7% in the 2nd quarter. First Horizon Advisors Inc. now owns 5,269 shares of the financial services provider’s stock worth $1,453,000 after purchasing an additional 36 shares in the last quarter. Great Lakes Advisors LLC increased its stake in CME Group by 2.3% in the 1st quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider’s stock valued at $441,000 after buying an additional 37 shares during the last quarter. Beaumont Financial Advisors LLC increased its stake in CME Group by 2.0% in the 2nd quarter. Beaumont Financial Advisors LLC now owns 1,952 shares of the financial services provider’s stock valued at $538,000 after buying an additional 38 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. lifted its position in shares of CME Group by 0.8% during the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 5,021 shares of the financial services provider’s stock worth $1,384,000 after buying an additional 38 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at CME Group

In related news, General Counsel Jonathan L. Marcus sold 392 shares of the business’s stock in a transaction on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the sale, the general counsel directly owned 7,851 shares in the company, valued at approximately $2,056,962. The trade was a 4.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Sunil Cutinho sold 11,896 shares of the firm’s stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the transaction, the insider owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 14,043 shares of company stock worth $3,791,486. Company insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. Deutsche Bank Aktiengesellschaft raised CME Group from a “hold” rating to a “buy” rating and increased their price target for the company from $266.00 to $300.00 in a research report on Thursday, October 23rd. Argus lowered their target price on CME Group from $308.00 to $295.00 in a research note on Friday, October 31st. Piper Sandler boosted their price target on shares of CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a report on Thursday. UBS Group decreased their price objective on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating for the company in a report on Thursday, October 23rd. Finally, Rothschild & Co Redburn lifted their price objective on shares of CME Group from $297.00 to $300.00 and gave the stock a “neutral” rating in a research report on Thursday, November 6th. Eight research analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, CME Group presently has a consensus rating of “Hold” and a consensus price target of $287.06.

CME Group Trading Up 1.4%

Shares of CME Group stock opened at $283.54 on Friday. The stock has a market capitalization of $102.24 billion, a P/E ratio of 27.47, a P/E/G ratio of 4.41 and a beta of 0.38. CME Group Inc. has a 52-week low of $222.56 and a 52-week high of $290.79. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The stock’s 50-day simple moving average is $266.87 and its 200 day simple moving average is $272.73.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.63 by $0.05. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The firm had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter last year, the company earned $2.68 earnings per share. The company’s revenue was down 3.0% on a year-over-year basis. As a group, research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th will be issued a dividend of $1.25 per share. The ex-dividend date of this dividend is Friday, December 12th. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. CME Group’s payout ratio is presently 48.45%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.